NXS 5.00% 21.0¢ next science limited

hartleys spec buy recommendation in the west

  1. 7 Posts.
    The west have printed a speculative buy recommendation in today's paper (4/2/12):

    "The market appeas to be punishing Nexus for not following through on the original Crux development. A market cap of $265 million and a look-through value for Crux of $637 million reflects value on its own but access to cash over the next year through the sale of Crux long lead items and the Crux 2 per cent option means Longtom can also be de-risked through the repayment of debt. Price 20.5c, target 32c."

    Chart looks like it may have bottomed out as well??
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.